A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil® HPV vaccine in mice

Ji Eun Han, Hye Kyeong Kim, Shin Ae Park, Seung Jae Lee, Hyoung Jin Kim, Ga Hyun Son, YoungTae Kim, Yang Je Cho, Hong Jin Kim, Na Gyong Lee

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Human papillomavirus (HPV) is the causative agent of cervical cancer, the second most common cause of cancer death in women worldwide. The licensed HPV vaccine Gardasil® from Merck & Co. is a quadrivalent vaccine containing virus-like particles (VLPs) of the L1 proteins from HPV types 6, 11, 16, and 18 adsorbed on aluminum salts (alum). CIA07 is an immunostimulatory agent comprised of bacterial DNA fragments (CIA02) and a nontoxic derivative of lipopolysaccharide (CIA05) that has been shown to have antitumor activity and adjuvant activity for viral and bacterial vaccine antigens. We investigated whether these CIAs are capable of promoting the immune response to Gardasil®. Balb/c mice were immunized intramuscularly twice three weeks apart with 1/20 human dose of Gardasil® alone or in combination with CIA02, CIA05 or both, and immune responses were assessed. The serum anti-HPV16 L1 VLP IgG antibody titer was significantly higher in mice administered CIA05 or CIA05 plus CIA02, but not in those given CIA02, compared with mice given Gardasil® alone. A secreted alkaline phosphatase (SEAP)-based pseudovirus neutralization assay showed increased neutralizing antibody titers in both CIA05 and CIA05 plus CIA02 groups. Coadministration of CIA05 with Gardasil® led to a marked increase in serum IgG2a antibody titer and the percentage of interferon (IFN)-γ+ cells in the spleen, indicating that CIA05 effectively promotes Th1-type immune responses. These data indicate that CIA05, in synergy with alum, enhances the immune response to HPV L1 VLPs and suggest its potential as an adjuvant for the development of a potent prophylactic HPV vaccine.

Original languageEnglish
Pages (from-to)169-176
Number of pages8
JournalInternational Immunopharmacology
Volume10
Issue number2
DOIs
Publication statusPublished - 2010 Feb 1

Fingerprint

Papillomavirus Vaccines
Lipopolysaccharides
Aluminum
Papillomaviridae
Virion
Virus-Like Particle Vaccines
Salts
Viral Vaccines
Bacterial Vaccines
Bacterial Antigens
Bacterial DNA
Antibodies
Neutralizing Antibodies
Serum
Uterine Cervical Neoplasms
Interferons
Alkaline Phosphatase
Cause of Death
Spleen
Immunoglobulin G

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pharmacology

Cite this

Han, Ji Eun ; Kim, Hye Kyeong ; Park, Shin Ae ; Lee, Seung Jae ; Kim, Hyoung Jin ; Son, Ga Hyun ; Kim, YoungTae ; Cho, Yang Je ; Kim, Hong Jin ; Lee, Na Gyong. / A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil® HPV vaccine in mice. In: International Immunopharmacology. 2010 ; Vol. 10, No. 2. pp. 169-176.
@article{ff65b1dff9c24868907712ba699e956d,
title = "A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil{\circledR} HPV vaccine in mice",
abstract = "Human papillomavirus (HPV) is the causative agent of cervical cancer, the second most common cause of cancer death in women worldwide. The licensed HPV vaccine Gardasil{\circledR} from Merck & Co. is a quadrivalent vaccine containing virus-like particles (VLPs) of the L1 proteins from HPV types 6, 11, 16, and 18 adsorbed on aluminum salts (alum). CIA07 is an immunostimulatory agent comprised of bacterial DNA fragments (CIA02) and a nontoxic derivative of lipopolysaccharide (CIA05) that has been shown to have antitumor activity and adjuvant activity for viral and bacterial vaccine antigens. We investigated whether these CIAs are capable of promoting the immune response to Gardasil{\circledR}. Balb/c mice were immunized intramuscularly twice three weeks apart with 1/20 human dose of Gardasil{\circledR} alone or in combination with CIA02, CIA05 or both, and immune responses were assessed. The serum anti-HPV16 L1 VLP IgG antibody titer was significantly higher in mice administered CIA05 or CIA05 plus CIA02, but not in those given CIA02, compared with mice given Gardasil{\circledR} alone. A secreted alkaline phosphatase (SEAP)-based pseudovirus neutralization assay showed increased neutralizing antibody titers in both CIA05 and CIA05 plus CIA02 groups. Coadministration of CIA05 with Gardasil{\circledR} led to a marked increase in serum IgG2a antibody titer and the percentage of interferon (IFN)-γ+ cells in the spleen, indicating that CIA05 effectively promotes Th1-type immune responses. These data indicate that CIA05, in synergy with alum, enhances the immune response to HPV L1 VLPs and suggest its potential as an adjuvant for the development of a potent prophylactic HPV vaccine.",
author = "Han, {Ji Eun} and Kim, {Hye Kyeong} and Park, {Shin Ae} and Lee, {Seung Jae} and Kim, {Hyoung Jin} and Son, {Ga Hyun} and YoungTae Kim and Cho, {Yang Je} and Kim, {Hong Jin} and Lee, {Na Gyong}",
year = "2010",
month = "2",
day = "1",
doi = "10.1016/j.intimp.2009.10.012",
language = "English",
volume = "10",
pages = "169--176",
journal = "International Immunopharmacology",
issn = "1567-5769",
publisher = "Elsevier",
number = "2",

}

A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil® HPV vaccine in mice. / Han, Ji Eun; Kim, Hye Kyeong; Park, Shin Ae; Lee, Seung Jae; Kim, Hyoung Jin; Son, Ga Hyun; Kim, YoungTae; Cho, Yang Je; Kim, Hong Jin; Lee, Na Gyong.

In: International Immunopharmacology, Vol. 10, No. 2, 01.02.2010, p. 169-176.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A nontoxic derivative of lipopolysaccharide increases immune responses to Gardasil® HPV vaccine in mice

AU - Han, Ji Eun

AU - Kim, Hye Kyeong

AU - Park, Shin Ae

AU - Lee, Seung Jae

AU - Kim, Hyoung Jin

AU - Son, Ga Hyun

AU - Kim, YoungTae

AU - Cho, Yang Je

AU - Kim, Hong Jin

AU - Lee, Na Gyong

PY - 2010/2/1

Y1 - 2010/2/1

N2 - Human papillomavirus (HPV) is the causative agent of cervical cancer, the second most common cause of cancer death in women worldwide. The licensed HPV vaccine Gardasil® from Merck & Co. is a quadrivalent vaccine containing virus-like particles (VLPs) of the L1 proteins from HPV types 6, 11, 16, and 18 adsorbed on aluminum salts (alum). CIA07 is an immunostimulatory agent comprised of bacterial DNA fragments (CIA02) and a nontoxic derivative of lipopolysaccharide (CIA05) that has been shown to have antitumor activity and adjuvant activity for viral and bacterial vaccine antigens. We investigated whether these CIAs are capable of promoting the immune response to Gardasil®. Balb/c mice were immunized intramuscularly twice three weeks apart with 1/20 human dose of Gardasil® alone or in combination with CIA02, CIA05 or both, and immune responses were assessed. The serum anti-HPV16 L1 VLP IgG antibody titer was significantly higher in mice administered CIA05 or CIA05 plus CIA02, but not in those given CIA02, compared with mice given Gardasil® alone. A secreted alkaline phosphatase (SEAP)-based pseudovirus neutralization assay showed increased neutralizing antibody titers in both CIA05 and CIA05 plus CIA02 groups. Coadministration of CIA05 with Gardasil® led to a marked increase in serum IgG2a antibody titer and the percentage of interferon (IFN)-γ+ cells in the spleen, indicating that CIA05 effectively promotes Th1-type immune responses. These data indicate that CIA05, in synergy with alum, enhances the immune response to HPV L1 VLPs and suggest its potential as an adjuvant for the development of a potent prophylactic HPV vaccine.

AB - Human papillomavirus (HPV) is the causative agent of cervical cancer, the second most common cause of cancer death in women worldwide. The licensed HPV vaccine Gardasil® from Merck & Co. is a quadrivalent vaccine containing virus-like particles (VLPs) of the L1 proteins from HPV types 6, 11, 16, and 18 adsorbed on aluminum salts (alum). CIA07 is an immunostimulatory agent comprised of bacterial DNA fragments (CIA02) and a nontoxic derivative of lipopolysaccharide (CIA05) that has been shown to have antitumor activity and adjuvant activity for viral and bacterial vaccine antigens. We investigated whether these CIAs are capable of promoting the immune response to Gardasil®. Balb/c mice were immunized intramuscularly twice three weeks apart with 1/20 human dose of Gardasil® alone or in combination with CIA02, CIA05 or both, and immune responses were assessed. The serum anti-HPV16 L1 VLP IgG antibody titer was significantly higher in mice administered CIA05 or CIA05 plus CIA02, but not in those given CIA02, compared with mice given Gardasil® alone. A secreted alkaline phosphatase (SEAP)-based pseudovirus neutralization assay showed increased neutralizing antibody titers in both CIA05 and CIA05 plus CIA02 groups. Coadministration of CIA05 with Gardasil® led to a marked increase in serum IgG2a antibody titer and the percentage of interferon (IFN)-γ+ cells in the spleen, indicating that CIA05 effectively promotes Th1-type immune responses. These data indicate that CIA05, in synergy with alum, enhances the immune response to HPV L1 VLPs and suggest its potential as an adjuvant for the development of a potent prophylactic HPV vaccine.

UR - http://www.scopus.com/inward/record.url?scp=75049085591&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=75049085591&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2009.10.012

DO - 10.1016/j.intimp.2009.10.012

M3 - Article

VL - 10

SP - 169

EP - 176

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

IS - 2

ER -